Get the Stockscreener App
4.48
5.49%
-0.26
After Hours:
4.56
0.08
+1.79%
Agenus Inc stock is traded at $4.48, with a volume of 354.08K.
It is down -5.49% in the last 24 hours and down -6.86% over the past month.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
See More
Previous Close:
$4.74
Open:
$4.69
24h Volume:
354.08K
Relative Volume:
0.41
Market Cap:
$142.75M
Revenue:
$160.43M
Net Income/Loss:
$-227.64M
P/E Ratio:
-0.0651
EPS:
-68.77
Net Cash Flow:
$-170.79M
1W Performance:
+3.46%
1M Performance:
-6.86%
6M Performance:
+140.21%
1Y Performance:
-24.45%
1-Day Range:
$4.47
$4.73
1-Week Range:
$4.21
$5.2001
52-Week Range:
$1.38
$7.34
Agenus Inc Stock (AGEN) Company Profile
Name
Agenus Inc
Sector
Industry
Phone
781-674-4410
Address
3 FORBES ROAD, LEXINGTON, MA
Compare AGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AGEN
Agenus Inc
|
4.48 | 153.90M | 160.43M | -227.64M | -170.79M | -68.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Agenus Inc Stock (AGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-04-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jul-19-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jul-18-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-18-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-06-23 | Initiated | Robert W. Baird | Outperform |
| Feb-28-23 | Resumed | H.C. Wainwright | Buy |
| Sep-28-22 | Initiated | SMBC Nikko | Outperform |
| Dec-16-21 | Initiated | H.C. Wainwright | Buy |
| Nov-19-19 | Resumed | B. Riley FBR | Buy |
| Apr-22-19 | Initiated | B. Riley FBR | Buy |
| Oct-28-16 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-27-16 | Reiterated | Maxim Group | Buy |
| Mar-11-16 | Upgrade | Maxim Group | Hold → Buy |
| Dec-16-15 | Initiated | Jefferies | Buy |
| Oct-27-15 | Downgrade | Maxim Group | Buy → Hold |
| Jul-27-15 | Reiterated | MLV & Co | Buy |
| Jun-11-15 | Initiated | Oppenheimer | Outperform |
| Jan-12-15 | Reiterated | Maxim Group | Buy |
| Jan-09-15 | Reiterated | MLV & Co | Buy |
| Jan-09-15 | Reiterated | Maxim Group | Buy |
| Dec-19-14 | Reiterated | Maxim Group | Buy |
| May-08-14 | Reiterated | Maxim Group | Buy |
| Mar-14-14 | Reiterated | MLV & Co | Buy |
| Oct-08-13 | Reiterated | Maxim Group | Buy |
| Jan-05-12 | Initiated | William Blair | Outperform |
| Dec-01-11 | Initiated | Global Hunter Securities | Buy |
View All
Agenus Inc Stock (AGEN) Latest News
Earnings call transcript: Agenus Q2 2025 focuses on cancer therapies - Investing.com India
Earnings call transcript: Agenus Q2 2025 focuses on cancer therapies By Investing.com - Investing.com Canada
Agenus' (AGEN) Buy Rating Reiterated at HC Wainwright - MarketBeat
Agenus stock gains as bot/bal granted compassionate use in France - Investing.com
France Grants Reimbursed Compassionate Access for BOT/BAL in Refractory MSS Colorectal Cancer - Oncodaily
Agenus (AGEN) Analyst Rating Update: HC Wainwright & Co. Reitera - GuruFocus
France Grants Reimbursed Compassionate Access (AAC) for Agenus’ BOT/BAL in Refractory MSS Metastatic Colorectal Cancer - BioSpace
Agenus’ cancer immunotherapy combo gets French compassionate access - Investing.com
Agenus at H.C. Wainwright Conference: Insights on Botensilimab - Investing.com
France authorizes reimbursed compassionate use of Agenus' BOT/BAL for MSS metastatic colorectal cancer - MarketScreener
Comparing Agenus Inc. in custom built stock radarsMarket Volume Report & Capital Efficient Trading Techniques - Newser
Agenus Posts 48% Q2 Revenue Miss - AOL.com
Can Agenus Inc. keep up with sector leaders2025 Performance Recap & Daily Entry Point Trade Alerts - خودرو بانک
What is Agenus Inc.’s TAM (Total Addressable Market)July 2025 Chart Watch & High Accuracy Trade Signal Alerts - خودرو بانک
Will Agenus Inc. bounce back from current supportJuly 2025 Intraday Action & Daily Volume Surge Trade Alerts - Newser
Is Agenus Inc. stock a good pick for beginners2025 Winners & Losers & Verified Momentum Stock Alerts - خودرو بانک
Is Agenus Inc.’s ROE strong enoughPortfolio Gains Summary & Weekly Top Stock Performers List - خودرو بانک
What MACD signals say about Agenus Inc.Earnings Overview Report & Free Technical Pattern Based Buy Signals - Newser
Agenus Inc. shares fall 2.22% intraday as the company prepares to participate in the H.C. Wainwright 27th Annual Global Investment Conference. - AInvest
What are Agenus Inc.’s earnings expectationsQuarterly Growth Report & Weekly Hot Stock Watchlists - خودرو بانک
Will Agenus Inc. benefit from macro trendsTrade Ideas & Scalable Portfolio Growth Methods - Newser
Agenus to Participate in the H.C. Wainwright 27th Annual Global Investment Conference | AGEN Stock News - GuruFocus
Agenus to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - The Globe and Mail
Agenus Inc. stock trend forecast2025 Market Outlook & Growth Focused Investment Plans - Newser
Technical signs of recovery in Agenus Inc.Market Performance Summary & Low Risk High Win Rate Stock Picks - Newser
Is Agenus Inc. still worth holding after the dipJuly 2025 Gainers & Free Real-Time Volume Trigger Notifications - Newser
Will Agenus Inc. stock recover after recent dropWall Street Watch & Verified Momentum Stock Ideas - Newser
Agenus Inc. Builds Base for Possible Rebound2025 Price Momentum & Capital Efficiency Focused Ideas - beatles.ru
Detecting support and resistance levels for Agenus Inc.2025 Price Momentum & Smart Investment Allocation Tips - Newser
Real time scanner hits for Agenus Inc. explainedBreakout Watch & Safe Capital Investment Plans - Newser
Using data tools to time your Agenus Inc. exit2025 Performance Recap & Detailed Earnings Play Strategies - Newser
Real time alert setup for Agenus Inc. performance2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - Newser
Is Agenus Inc. part of any major index2025 Biggest Moves & Risk Controlled Stock Pick Alerts - خودرو بانک
Real time pattern detection on Agenus Inc. stockDividend Hike & AI Enhanced Trade Execution Alerts - Newser
Is Agenus Inc. forming a bullish divergenceMarket Sentiment Report & Community Consensus Picks - خودرو بانک
How moving averages guide Agenus Inc. tradingTrade Entry Summary & Target Return Focused Stock Picks - Newser
Can Agenus Inc. navigate macro headwindsWeekly Market Report & Consistent Profit Focused Trading Strategies - خودرو بانک
What is Agenus Inc. s revenue forecast2025 Investor Takeaways & Low Drawdown Momentum Trade Ideas - خودرو بانک
Can Agenus Inc. grow without external fundingJuly 2025 Gainers & Verified Chart Pattern Signals - خودرو بانک
Can Agenus Inc. disrupt its industryQuarterly Portfolio Report & Weekly Breakout Watchlists - خودرو بانک
Is Agenus Inc. exposed to currency risks2025 Trade Ideas & Safe Capital Growth Stock Tips - خودرو بانک
Is Agenus Inc.’s ROIC above industry average2025 Buyback Activity & Stepwise Swing Trade Plans - خودرو بانک
Using Python tools to backtest Agenus Inc. strategiesJuly 2025 Institutional & Weekly Stock Performance Updates - Newser
Agenus Inc. Could See a Relief Rally From Support getLinesFromResByArray error: size == 0 - 더경남뉴스
How to build a dashboard for Agenus Inc. stockFed Meeting & Target Return Focused Stock Picks - Newser
Agenus Inc Stock (AGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):